Zeynep DURU, Necati DURU, Bekir KÜÇÜK, Ender SIRAKAYA

Monocyte / high-density lipoprotein ratio and neutrophilto- lymphocyte ratio in age-related macular degeneration

Aim To evaluate the monocyte/high-density lipoprotein (HDL) ratio (MHR) and neutrophil-to-lymphocyte ratio (NLR) as biomarkersof systemic inflammation in age-related macular degeneration (AMD).Materials and Methods: HDL, hematological profiles, erythrocyte sedimentation rates, C-reactive protein, MHRs, and NLRs wereevaluated in 30 patients with neovascular AMD (Group 1), 30 with non-neovascular AMD (Group 2), and 30 controls (Group 3).Results: MHRs and NLRs were significantly higher in Group 1 than in Group 3 (p = 0.002 and p < 0.001, respectively) and wereindependent predictors of neovascular AMD in multivariate analysis (odds ratio = 1.231 and 3.332; 95% confidence interval = 1.035–1.466 and 1.385–8.019; p = 0.019 and 0.007, respectively). The areas under the receiver operating characteristics curve for MHRand NLR were 0.669 and 0.769. The sensitivity and specificity of MHRs and NLRs in predicting neovascular AMD were 47% and 97%versus 63% and 80%, respectively.Conclusions: By reflecting the balance of pro- and anti-inflammatory responses, the MHR can reliably indicate systemic inflammationin AMD.

PDF

___

1. 1. Congdon NB. O’Colmain C. Klaver R. et al, Causes and prevalence of visual impairment among adults in the United Sta-tes. Arch Ophthalmol 2004;122:477-85.
2. McGEER, PL. McGEER EG. Inflammation and the degenerative diseases of aging. Ann N Y Acad Sci 2004;1035:104-16.
3. Ambati J, Atkinson JP, Gelfand BD. Immunology of agerelated macular degeneration. Nat Rev Immunol 2013;13:438-51.
4. Chiu CJ, Chang ML, Zhang FF et al. The relationship of major American dietary patterns to age-related macular degenera-tion. Am J Ophthalmol 2014;158:118-27.
5. Rangasamy T, Cho CY, Thimmulappa RK, et al. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke– induced emphysema in mice. J Clin Invest 2004;114:1248- 59.
6. Canter JA, Olson LM, Spencer K, et al. Mitochondrial DNA polymorphism A4917G is independently associated with age-related macular degeneration. PLoS One 2008;3:e2091.
7. SanGiovanni JP, Arking DE, Iyengar SK, et al. Mitochondrial DNA variants of respiratory complex I that uniquely 8. characterize haplogroup T2 are associated with increased risk of age-related macular degeneration. PLoS One, 2009;4:e5508.
9. Rodrigues EB. Inflammation in dry age-related macular degeneration. Ophthalmologica 2007;221:143-52.
10. Anderson DH, Mullins RF, Hageman GS, et al, A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 2002;134:411-31.
11. Kurtul BE, Ozer PA. The relationship between neutrophiltolymphocyte ratio and age-related macular degeneration. Korean J Ophthalmol 2016;30:377-81.
12. Boekhoorn SS, Vingerling JR, Witteman JC, et al. C-reactive protein level and risk of aging macula disorder: The Rotterdam Study. Arch Ophthalmol 2007;125:1396-401.
13. Bolayir A, Gokce SF, Cigdem B et al. Monocyte/high-density lipoprotein ratio predicts the mortality in ischemic stroke pa-tients. Neurol Neurochir Pol 2018;52:150-5.
14. Korkmaz A, Demir M, Unal S, et al. Monocyte-to-high density lipoprotein ratio (MHR) can predict the significance of an-giographically intermediate coronary lesions. Int J Cardiovasc Acad 2017;3:16-20.
15. Mirza E, Oltulu R FEBO, Katipoğlu Z, et al. Monocyte/HDL ratio and lymphocyte/Monocyte ratio in patients with pseudoexfoliation syndrome. Ocul Immunol Inflamm 2018:1-5.
16. Şatırtav GE, Mirza R, Oltulu GD, et al. Assessment of Monocyte/HDL Ratio in branch retinal vein occlusion. Ocul Immu-nol Inflamm 2019:1-5.
17. Donoso LA, Kim AD, Frost A. et al. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2006;51:137-52.
18. Swanson MW, McGwin G Jr. Anti-inflammatory drug use and age-related macular degeneration. Optom Vis Sc 2008;85:947-50.
19. Guymer RH, Tao LW, Goh JK, et al. Identification of urinary biomarkers for age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52:4639-44.
20. Reynolds R, Hartnett ME, Atkinson JP, et al. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci 2009;50:5818-27.
21. Hecker LA, Edwards AO, Ryu E, et al. Genetic control of the alternative pathway of complement in humans and agerelated macular degeneration. Hum Mol Genet 2009;19:209-15.
22. Cao S, Ko A, Partanen M, et al. Relationship between systemic cytokines and complement factor H Y402H polymorphism in patients with dry age-related macular degeneration. Am J Ophthalmol 2013;156:1176-83.
23. Cousins SW, Espinosa-Heidmann DG, Csaky KG. Monocyte activation in patients with age-related macular degeneration: a biomarker of risk for choroidal neovascularization? Arch Ophthalmol 2004;122:1013-8.
24. Oh H, Takagi H, Takagi C, et al. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1999;40:1891-8.
25. Abdulaeva E. The role of complement system and other inflammatory factors in the development of age-related 26. macular degeneration. Kazan Med J 2018;99:657-64.
27. Ucar FM. A potential marker of bare metal stent restenosis: monocyte count-to-HDL cholesterol ratio. BMC Cardiovasc Disord 2016;16:186.
28. Ahsen A, Ulu MS, Yuksel S, et al. As a new inflammatory marker for familial Mediterranean fever: neutrophiltolymphocyte ratio. Inflammation 2013;36:1357-62.
29. Turkmen K, Ozcicek F, Ozcicek Ozcicek, et al. The relationship between neutrophilto-lymphocyte ratio and vascular 30. calcification in endstage renal disease patients. Hemodial Int 2014;18:47-53.
31. Kim HA, Jung JY, Suh CH, et al. Usefulness of neutrophiltolymphocyte ratio as a biomarker for diagnosing infections in patients with systemic lupus erythematosus. Clin Rheumatol 2017;36:2479-85.
32. Ozgonul C, Sertoglu E, Ayyildiz O, et al. Novel biomarkers for patients with idiopathic acute anterior uveitis: neutrophil to lymphocyte ratio and platelet to lymphocyte ratio. Int J Ophthalmol 2017;10:262.
33. Ilhan N, Daglioglu MC, Ilhan MC, et al. Assessment of neutrophil/lymphocyte ratio in patients with age-related macular degeneration. Ocul Immunol Inflamm 2015;23:287- 90.
34. Sekeryapan B, Uzun F, Buyuktarakci S, et al. Neutrophiltolymphocyte ratio increases in patients with dry eye. Cornea 2016;35:983-6.
35. Dursun A, Ozturk S, Yucel H, et al. Association of neutrophil/ lymphocyte ratio and retinal vein occlusion. Eur J Ophthalmol 2015;25:343-6.
36. Ulu SM, Dogan M, Ahsen A, et al. Neutrophil-to-lymphocyte ratio as a quick and reliable predictive marker to diagnose the severity of diabetic retinopathy. Diabetes Technol Ther 2013;15:942-7.
37. Yue S, Zhang J, Wu J, et al. Use of the monocytetolymphocyte ratio to predict diabetic retinopathy. Int J Environ Res Public Health 2015;12:10009-19.
38. Grossniklaus HE, Ling JX, Wallace TM, et al. Macrophage and retinal pigment epithelium expression of angiogenic 39. cytokines in choroidal neovascularization. Mol Vis 2002;8:119-26.
40. Peter I, Huggins GS, Ordovas JM, et al. Evaluation of new and established age-related macular degeneration susceptibility genes in the Women’s Health Initiative Sight Exam (WHI-SE) Study. Am J Ophthalmol 2011;152:1005-13.
41. Cho BJ, Heo JW, Kim TW, et al. Prevalence and risk factors of age-related macular degeneration in Korea: the Korea 42. National Health and Nutrition Examination Survey 2010– 2011. Invest Ophthalmol Vis Sci 2014;55:1101-8.
43. Reynolds R, Rosner B, Seddon JM. Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration. Ophthalmology 2010;117:1989-95.